Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-05-27 4:44 pm Purchase | 2021-05-24 | 13G | KalVista Pharmaceuticals, Inc. KALV | RA CAPITAL MANAGEMENT L.P. | 1,399,489 5.700% | 613,219 (+77.99%) | Filing History |
| 2021-05-07 4:56 pm Purchase | 2021-04-27 | 13G | KalVista Pharmaceuticals, Inc. KALV | Deerfield Mgmt, L.P. | 1,806,037 7.430% | 1,806,037 (New Position) | Filing History |
| 2021-02-16 4:03 pm Sale | 2021-02-09 | 13D | KalVista Pharmaceuticals, Inc. KALV | SVLSF IV LLC | 0 0.000% | -1,769,576 (Position Closed) | Filing History |
| 2021-02-16 08:31 am Purchase | 2020-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | Ikarian Capital, LLC | 1,063,961 5.900% | 117,356 (+12.40%) | Filing History |
| 2021-02-12 4:30 pm Purchase | 2020-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | Vivo Ventures VI LLC | 1,383,179 5.900% | 1,383,179 (New Position) | Filing History |
| 2021-02-08 10:25 am Sale | 2021-02-05 | 13G | KalVista Pharmaceuticals, Inc. KALV | FMR LLC | 1,640,278 9.142% | -150,513 (-8.40%) | Filing History |
| 2021-02-02 2:56 pm Purchase | 2020-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | BlackRock Inc. BLK | 1,113,380 6.200% | 1,113,380 (New Position) | Filing History |